- BOCEPREVIR
[作者:Rizza, SA; Talwani, R; Nehra, V; Temesgen, Z,期刊:Drugs of today, 页码:743-751 , 文章类型: Article,,卷期:2011年47-10]
- Boceprevir is a hepatitis C virus (HCV) serine protease NS3 inhibitor that has recently been approved by the U.S. Food and Drug Administration, the European Medicines Agency and Health Canada for the treatment of chronic...
- CURRENT TREATMENT OPTIONS FOR NEUROENDOCRINE TUMORS
[作者:Horsch, D; Grabowski, P; Schneider, CP; Petrovitch, A; Hommann, M; Kammerer, D; Baum, RP,期刊:Drugs of today, 页码:773-786 , 文章类型: Review,,卷期:2011年47-10]
- Neuroendocrine tumors are heterogeneous in their clinical behavior and require therapies specially tailored according to staging and grading, origin and expression of peptide receptors. Somatostatin analogues act as anti...
|